Agenus Inc (AGEN.O)

AGEN.O on Consolidated Issue listed on NASDAQ Capital Market

5.28USD
5 Mar 2015
Change (% chg)

-- (--)
Prev Close
$5.28
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
2,184,131
52-wk High
$6.49
52-wk Low
$2.27

AGEN.O

Chart for AGEN.O

About

Agenus Inc. including its subsidiaries (Agenus) is an immuno-oncology company developing a portfolio of checkpoint modulators (CPMs), heat shock protein peptide-based vaccines and adjuvants. The Company’s core technology portfolio consists of Retrocyte Display technology platform and checkpoint modulator antibody programs (CPM... (more)

Overall

Beta: 1.71
Market Cap(Mil.): $344.76
Shares Outstanding(Mil.): 62.68
Dividend: --
Yield (%): --

Financials

  AGEN.O Industry Sector
P/E (TTM): -- 175.69 40.21
EPS (TTM): -0.45 -- --
ROI: -44.55 -2.61 16.34
ROE: -97.80 -4.39 17.27
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25
Provider: ValuEngine, Inc.
$49
Provider: ValuEngine, Inc.
$25
Provider: Pechala's Reports
$25
Provider: TheStreet.com Ratings
$10

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks